L-Pyroglutamic acid
- Iupac Name:(2S)-5-oxopyrrolidine-2-carboxylic acid
- CAS No.: 98-79-3
- Molecular Weight:129.11398
- Modify Date.: 2022-10-28 01:35
- Introduction: 1. It can be used as a kind of intermediates of organic synthesis as well as food additives.2. It is used in food, medicine, cosmetics and other industries
View more+
1. Names and Identifiers
- 1.1 Name
- L-Pyroglutamic acid
- 1.2 Synonyms
(5s)-2-oxopyrrolidine-5-carboxylicacid (s)-5-oxo-2-pyrrolidinecarboxylicacid (s)-pyroglutamicacid 2-benzothiazolesulfenicacidmorpholide 2-l-pyrrolidone-5-carboxylicacid 2-oxopyrrolidine-5-carboxylicacid 2-pyrrolidone-5-carboxylate 5 oxoproline EINECS 202-700-3 glutimicacid H-Pyr-OH hydroxy-pyridin-3-yl-acetic acid L-Pyroglutamicacid MFCD00005272
- View all
- 1.3 CAS No.
- 98-79-3
- 1.4 CID
- 7405
- 1.5 EINECS(EC#)
- 202-700-3
- 1.6 Molecular Formula
- C5H7NO3 (isomer)
- 1.7 Inchi
- InChI=1S/C5H7NO3/c7-4-2-1-3(6-4)5(8)9/h3H,1-2H2,(H,6,7)(H,8,9)/t3-/m0/s1
- 1.8 InChIkey
- ODHCTXKNWHHXJC-VKHMYHEASA-N
- 1.9 Canonical Smiles
- C1CC(=O)NC1C(=O)O
- 1.10 Isomers Smiles
- C1CC(=O)N[C@@H]1C(=O)O
2. Properties
- 2.1 Density
- 1.38
- 2.1 Melting point
- 152-162℃
- 2.1 Boiling point
- 453.1 °C at 760 mmHg
- 2.1 Refractive index
- -10 ° (C=5, H2O)
- 2.1 Flash Point
- 227.8 °C
- 2.1 Precise Quality
- 129.04300
- 2.1 PSA
- 66.40000
- 2.1 logP
- -0.32160
- 2.1 Solubility
- 10-15 g/100 mL (20 oC)
- 2.2 Appearance
- White fine crystals
- 2.3 Storage
- Ambient temperatures.
- 2.4 Color/Form
- White to off-white
- 2.5 PH
- 1.7 (50g/l, H2O, 20℃)
- 2.6 pKa
- 3.32(at 25℃)
- 2.7 Water Solubility
- 10-15 g/100 mL (20 oC)
- 2.8 Stability
- Stable. Incompatible with bases, acids, strong oxidizing agents.
- 2.9 StorageTemp
- 2-8°C
3. Use and Manufacturing
- 3.1 Definition
- ChEBI: An optically active form of 5-oxoproline having L-configuration.
- 3.2 Purification Methods
- Crystallise S-pyroglutamic acid by dissolving it in boiling EtOH (20g in 100mL), cooling and after a few minutes additing pet ether (b 40-60o, 120mL), then after 5 minutes adding a further 120mL, and coThis has m 155.5-157.5o and [] D -11.4o (c 4.4, H2O) [Hardy Synthesis 290 1978, Pellegata et al. Synthesis 614 1978]. The NH4 salt has m 184-186o (from EtOH). [Beilstein 22/6 V 7.] L-Pyroglutamic acid Preparation Products And Raw materials Raw materials
- 3.3 Usage
- 1. It can be used as a kind of intermediates of organic synthesis as well as food additives.2. It is used in food, medicine, cosmetics and other industries
4. Safety and Handling
- 4.1 Hazard Codes
- Xi
- 4.1 Risk Statements
- R36/37/38
- 4.1 Safety Statements
- S26;S36
- 4.1 Hazard Class
- IRRITANT
- 4.1 RIDADR
- NONH for all modes of transport
- 4.1 WGK Germany
- 3
- 4.1 RTECS
- TW3710000
- 4.1 Toxicity
-
CHEMICAL IDENTIFICATION
- RTECS NUMBER :
- TW3710000
- CHEMICAL NAME :
- Proline, 5-oxo-, L-
- CAS REGISTRY NUMBER :
- 98-79-3
- LAST UPDATED :
- 199807
- DATA ITEMS CITED :
- 2
HEALTH HAZARD DATA
ACUTE TOXICITY DATA
- TYPE OF TEST :
- LD50 - Lethal dose, 50 percent kill
- ROUTE OF EXPOSURE :
- Oral
- SPECIES OBSERVED :
- Rodent - rat
- DOSE/DURATION :
- >1 gm/kg
- TOXIC EFFECTS :
- Details of toxic effects not reported other than lethal dose value
- REFERENCE :
- USXXAM United States Patent Document. (U.S. Patent Office, Box 9,
Washington, DC 20231) Volume(issue)/page/year: #4882359
- TYPE OF TEST :
- LD50 - Lethal dose, 50 percent kill
- ROUTE OF EXPOSURE :
- Subcutaneous
- SPECIES OBSERVED :
- Rodent - rat
- DOSE/DURATION :
- >2 gm/kg
- TOXIC EFFECTS :
- Details of toxic effects not reported other than lethal dose value
- REFERENCE :
- USXXAM United States Patent Document. (U.S. Patent Office, Box 9,
Washington, DC 20231) Volume(issue)/page/year: #4882359
- View all
5. MSDS
2.Hazard identification
2.1 Classification of the substance or mixture
Serious eye damage, Category 1
2.2 GHS label elements, including precautionary statements
Pictogram(s) | |
Signal word | Danger |
Hazard statement(s) | H318 Causes serious eye damage |
Precautionary statement(s) | |
Prevention | P280 Wear protective gloves/protective clothing/eye protection/face protection. |
Response | P305+P351+P338 IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses, if present and easy to do. Continue rinsing. P310 Immediately call a POISON CENTER/doctor/\u2026 |
Storage | none |
Disposal | none |
2.3 Other hazards which do not result in classification
none
7. Synthesis Route
98-79-3Total: 1 Synthesis Route
8. Other Information
- 8.0 Merck
- 14,8001
- 8.1 BRN
- 82132
- 8.2 Characteristics and Application
- L-pyroglutamic acid is an amino acid that occurs naturally in the body. It is present in the brain, spinal fluid, skin and blood.
pyroglutamic acid is one of the major components of natural moisturizing factor of the skin, its moisturizing ability is far stronger than glycerin and propylene glycol. Moreover, it is non-toxic, non-irritating, and is an excellent raw material for modern skin care, and hair care cosmetics. Pyroglutamic acid also has inhibitory effect on the tyrosine oxidase activity, and thus preventing "melanoidins" substance from being deposited in the skin, and having a whitening effect on the skin. It has a keratin softening effect which can be used in nail cosmetics.
In addition to be applied in cosmetics, L-pyroglutamic acid derivatives can also have reaction with a number of other organic compounds for synthesis of derivatives. It also has some special effect on the surface activity and brilliant effect. Moreover, it can also be used as surfactants for detergents; as a chemical reagent, it can be used for the resolution of racemic amines; it can also be used as a kind of organic intermediates. - View all
- 8.3 Pyroglutamic acid
- Pyroglutamic acid is a kind of based 5-oxo-proline. It is produced by the dehydration and formation of intramolecular amide bond between the α-NH2 group and γ-hydroxy of glutamic acid; the molecule can also be produced from glutamine by losing its intramolecular amine group. The condition of glutathione synthetase deficiency can cause the anemia of pyroglutamic acid with a series of clinical symptoms. Pyroglutamic acid anemia is a kind of organic acid metabolic disorder disease caused by glutathione synthetase hyperlipidemia. Clinical manifestations: disease onset occurs within 12 to 24 hours of born with progressive hemolysis, jaundice, chronic metabolic acidosis, mental retardation; urine containing pyroglutamic acid, lactic acid, α-deoxy-4-hydroxyphenyl acetyl acid lactone. For treatment, based on the actual symptoms, pay attention to adjust the diet after yearling.
- 8.4 Preparation
- L-pyroglutamic acid is formed by removing one intramolecular water molecule in the L-glutamic acid; the preparation process is simple with the key step being the control of the temperature and dehydration time.
(1) Add100 g of L-glutamic acid into a 500-ml beaker; heat the beaker in an oil bath until the temperature was raised to 145~150 °C, incubate for 45 minutes to perform dehydration reaction. The dehydrated solution was brown.
(2) After the end of dehydration reaction, pour the solution into a volume of about 350 ml of boiling water with a solution of all further being dissolved in water. Cool to 40~50 °C, add appropriate amount of activated carbon for decolorization (repeated twice) to obtain a colorless transparent solution.
(3) directly heat and evaporate the colorless and transparent solution of the step (2) is a colorless and transparent solution for concentration to a half of the previous volume and then continue for concentration in a water bath to a volume of about 1/3 of the previous solution, and then stop heating; have it slightly cooled in the hot water bath for crystallization; the colorless prisms can be obtained after 10 to 20 hours.
The applied amount of L-pyroglutamic acid in cosmetics should depend on the formula. This product can also be applied to cosmetic in the form of 50% concentrated solution. - View all
- 8.5 Chemical Properties
- It is colorless crystals with the melting point being 162-163 °C; it is soluble in water, alcohol, acetone and acetic acid, slightly soluble in ethyl acetate, but insoluble in ether.
- 8.6 Uses
- L-Pyroglutamic acid is used in the synthesis of:
Nonproteinogenic amino acids such as (3S,4R)-3,4-dimethyl-L-pyroglutamic acid and (3S,4R)-3,4-dimethyl-L-glutamine.
Chiral N-heterocyclic carbenes (NHCs) as catalysts for the asymmetric dimerization of alkylarylketenes to give the corresponding α-quaternary β-alkylidenyl-β-lactones.
It is also used in the total synthesis of (?)-stemoamide and celogentin C.
It can be used as a kind of intermediates of organic synthesis as well as food additives.
It is used in food, medicine, cosmetics and other industries.
- 8.7 Production method
- There are semi-synthetic methods, enzymatic conversion method and total synthesis method. Currently the major approach of industrial production is the semi-synthetic method with glutamic acid being the raw material. Have the 42% of glutamic acid solution heated at 140 °C for 3h to obtain the reaction solution with L-pyroglutamic acid being the major component. The reaction solution further undergoes concentration under reduced pressure, crystallization, washing, and drying to obtain the L-pyroglutamic acid with the conversion rate being 94%.
- 8.8 Chemical Properties
- L-pyroglutamic acid has its scientific name being L-2-pyrrolidone-5-carboxylic acid. Precipitation from ethanol and petroleum ether mixture were colorless orthorhombic bipyramid crystals with the melting temperature being 162~163 °C. It is soluble in water, alcohol, acetone and acetic acid, slightly soluble in ethyl acetate, and insoluble in ether. Specific rotation-11.9 ° (c = 2, H2O). It is produced from 42% aqueous solution of glutamic acid which subjects to heating dehydration, concentration, crystallization, washing and drying to obtain L-pyroglutamic acid.
- 8.9 Uses
- L-Pyroglutamic acid is an amino acid that is used in the synthesis of peptides. It has also been observed to convert when placed at the N-terminus in vivo to create IgG2 antibodies.
- 8.10 Uses
- A building block for pharmaceuticals and asymmetric synthesis
- 8.11 Uses
- In the resolution of racemic amines.
- 8.12 Definition
- ChEBI: An optically active form of 5-oxoproline having L-configuration.
- 8.13 Purification Methods
- Crystallise S-pyroglutamic acid by dissolving it in boiling EtOH (20g in 100mL), cooling and after a few minutes additing pet ether (b 40-60o, 120mL), then after 5 minutes adding a further 120mL, and coThis has m 155.5-157.5o and [] D -11.4o (c 4.4, H2O) [Hardy Synthesis 290 1978, Pellegata et al. Synthesis 614 1978]. The NH4 salt has m 184-186o (from EtOH). [Beilstein 22/6 V 7.]
- 8.14 Usage
- (S)-(-)-2-Pyrrolidinone-5-carboxylic acid is used as a building block for pharmaceuticals and asymmetric synthesis. It Is also used as a resolving agent for chiral bases and in an efficient synthesis of quinolizidine and indolizidine alkaloids.
9. Computational chemical data
- Molecular Weight: 129.11398g/mol
- Molecular Formula: C5H7NO3
- Compound Is Canonicalized: True
- XLogP3-AA: -0.8
- Exact Mass: 129.042593085
- Monoisotopic Mass: 129.042593085
- Complexity: 154
- Rotatable Bond Count: 1
- Hydrogen Bond Donor Count: 2
- Hydrogen Bond Acceptor Count: 3
- Topological Polar Surface Area: 66.4
- Heavy Atom Count: 9
- Defined Atom Stereocenter Count: 1
- Undefined Atom Stereocenter Count: 0
- Defined Bond Stereocenter Count: 0
- Undefined Bond Stereocenter Count: 0
- Isotope Atom Count: 0
- Covalently-Bonded Unit Count: 1
- CACTVS Substructure Key Fingerprint: AAADcYBiMAAAAAAAAAAAAAAAAAAAAWAAAAAAAAAAAAAAAAAAAAAAHgAQCAAACCjBgAQACALAAgAIAAGQGAAAAAAAAAAAAIGIAAACABIAgCAEQAAEFgCQAACcFwAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAA==
10. Recommended Suppliers
-
- Products:Sulindac?Acid?;Roxadustat;Upadacitinib;Relugolix;Moxifloxacin;Ticagrelor;Valsartan;Ivabradine;Fingolimod;Fluvoxamine ;HPMC;PVP;Emagliflozine;D-Cycloserine;D-Proline;L-Proline;L-tert-Leucine
- Tel:86-571-87758773
- Email:balas@utanpharma.com
-
- Products:Pharmaceutical Intermediate , Apis , Food Additives , Herbal Extracts , Fine Chemicals , ...
- Tel:00-86-13023277276
- Email:hanna@xljxcl.com
-
- Products:We are engaged in the development, marketing and sales of apis, intermediates, natural products (extracts), fine chemicals, food additives, agricultural chemicals and other products.
- Tel:0086-0319-19133911216
- Email:Jany1001@chengcaibio.com
-
- Products:Pharmaceutical retail; Calendar wholesale; Veterinary drug management
- Tel:+86-185-33194109
- Email:berry@cetengbiology.com
-
- Products:Cosmetic Raw Materials,solvents,etc.
- Tel:86-311-66562153
- Email:breeduan@crovellbio.com
11. Realated Product Infomation